Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

A Recent FDA Approval Will Be Huge in Moving Amarin Stock

By Chris Lau, InvestorPlace Contributor

FDA approval of Vascepa in use for cardiovascular events just widened Amarin’s revenue potential. Amarin stock should have a banner 2020.

Why Qualcomm Stock Will Break Out to the Upside

By Chris Lau, InvestorPlace Contributor

Qualcomm has a lot in store for 2020 from 5G chips for Apple, ARM processors for laptops, and much more. That's good for QCOM stock.

7 Investing Resolutions to Follow in 2020

By Chris Lau, InvestorPlace Contributor

While you're going to the gym and starting a diet, why not make some investing resolutions? Try to avoid fad stocks and demand dividends.

Troubles for Aurora Cannabis Are Bound to Continue in 2020

By Chris Lau, InvestorPlace Contributor

After an unrelenting decline since the start of 2019, Aurora Cannabis (NYSE:ACB) may continue its dramatic drop in 2020. The sudden executive changes, a stock…

7 Excellent Value Stocks to Buy for 2020  

By Chris Lau, InvestorPlace Contributor

As investors shift their money to value stocks in 2020, check out these names that all have massive upside potential ahead.

Load More